Coravos Andrea, Doerr Megan, Goldsack Jennifer, Manta Christine, Shervey Mark, Woods Beau, Wood William A
Elektra Labs, Boston, MA USA.
2Harvard-MIT Center for Regulatory Science, Boston, MA USA.
NPJ Digit Med. 2020 Mar 13;3:37. doi: 10.1038/s41746-020-0237-3. eCollection 2020.
This manuscript is focused on the use of connected sensor technologies, including wearables and other biosensors, for a wide range of health services, such as collecting digital endpoints in clinical trials and remotely monitoring patients in clinical care. The adoption of these technologies poses five risks that currently exceed our abilities to evaluate and secure these products: (1) validation, (2) security practices, (3) data rights and governance, (4) utility and usability; and (5) economic feasibility. In this manuscript we conduct a landscape analysis of emerging evaluation frameworks developed to better manage these risks, broadly in digital health. We then propose a framework specifically for connected sensor technologies. We provide a pragmatic guide for how to put this evaluation framework into practice, taking lessons from concepts in drug and nutrition labels to craft a connected sensor technology label.
本手稿聚焦于连接传感器技术的应用,包括可穿戴设备和其他生物传感器,用于广泛的健康服务,如在临床试验中收集数字终点以及在临床护理中远程监测患者。采用这些技术带来了五个目前超出我们评估和保障这些产品能力的风险:(1)验证;(2)安全措施;(3)数据权利与治理;(4)效用与可用性;以及(5)经济可行性。在本手稿中,我们对为更好地管理这些风险而开发的新兴评估框架进行了全景分析,这些框架广泛应用于数字健康领域。然后,我们提出了一个专门针对连接传感器技术的框架。我们提供了一份实用指南,说明如何将这个评估框架付诸实践,借鉴药物和营养标签中的概念来制定连接传感器技术标签。